Last update 08 May 2025

Guangzhou Jiankangyuan Respiratory Medicine Engineering

Subsidiary Company|2015|Guangdong Sheng, China

Overview

Related

1
Drugs associated with Guangzhou Jiankangyuan Respiratory Medicine Engineering
Tobramycin
Target
30S subunit
Mechanism
30S subunit inhibitors
Active Org.
Viatris Healthcare (Pty) Ltd. [+13]
Originator Org.
Eli Lilly & Co.Eli Lilly & Co.
Active Indication
Bronchiectasis [+19]
Inactive Indication
Cataract [+4]
Drug Highest PhaseApproved
First Approval Ctry. / Loc.
United States
First Approval Date12 Dec 1980
1
Clinical Trials associated with Guangzhou Jiankangyuan Respiratory Medicine Engineering
CTR20182034
/ CompletedPhase 3
妥布霉素吸入溶液治疗伴肺部铜绿假单胞菌感染的支气管扩张症有效性和安全性研究
[Translation] Efficacy and safety of tobramycin inhalation solution in the treatment of bronchiectasis with Pseudomonas aeruginosa pulmonary infection
100 Clinical Results associated with Guangzhou Jiankangyuan Respiratory Medicine Engineering
Login to view more data
0 Patents (Medical) associated with Guangzhou Jiankangyuan Respiratory Medicine Engineering
Login to view more data
100 Deals associated with Guangzhou Jiankangyuan Respiratory Medicine Engineering
Login to view more data
100 Translational Medicine associated with Guangzhou Jiankangyuan Respiratory Medicine Engineering
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 31 May 2025

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Other
1
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
Tobramycin
 ( 30S subunit )		Pseudomonas aeruginosa infection
More
Pending
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free